Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial
{{output}}
Background and aims: Data describing the long-term efficacy, safety, and tolerability of inclisiran are limited. This was explored in ORION-8, an open-label extension study of preceding Phase 2 and Phase 3 placebo-controlled and ... ...
